mDR Limited Provides Detailed Update on Use of Proceeds from Rights cum Warrants Issue
Key Highlights
- Net Proceeds Raised: S\$30.624 million from the Rights cum Warrants Issue, after deducting associated costs and expenses.
- Current Utilisation: S\$16.709 million has been allocated and utilised for key purposes.
- Balance Remaining: S\$13.915 million in net proceeds remain available for future deployment.
- Alignment with Intended Use: Utilisation is consistent with plans disclosed in the Offer Information Statement (OIS).
- Ongoing Disclosure: The company will continue to provide updates as and when additional funds are materially utilised.
Details of Proceeds Utilisation
mDR Limited, incorporated in Singapore, has announced an update regarding the use of net proceeds from its recent Rights cum Warrants Issue. The company, together with its subsidiaries, raised a net total of S\$30.624 million after deducting approximately S\$0.31 million in expenses and setting off outstanding loan amounts (which did not result in new cash proceeds).
Breakdown of Utilisation
| Purpose | Amount Utilised (S\$’000) |
|---|---|
| Investment in quoted securities | 6,814 |
| Purchase of inventories | 7,978 |
| Payment of supplier invoices | 1,917 |
| Total Utilised | 16,709 |
| Balance of net proceeds | 13,915 |
Implications for Shareholders
- The company’s use of proceeds is fully in line with the intended allocation disclosed in the OIS, indicating strong governance and transparency.
- The substantial investment in quoted securities (S\$6.814 million) and inventories (S\$7.978 million) signals strategic initiatives that may drive future growth and operational capacity.
- The remaining S\$13.915 million provides the company with flexibility to pursue further growth opportunities, manage working capital, or respond to unexpected market developments.
- Any future material utilisation of the balance will be announced, which may impact the company’s financial position and thus, its share price.
Potential Price-Sensitive Information
- Deployment of Proceeds: Investors should closely monitor upcoming announcements regarding the use of the remaining S\$13.915 million, as major investments or acquisitions could impact share value.
- Alignment with OIS: Assurance that funds are used as intended may support investor confidence and affect market sentiment.
Conclusion
mDR Limited’s responsible disclosure and transparent allocation of the Rights cum Warrants Issue proceeds reaffirm its commitment to shareholder interests. Investors should remain attentive to future disclosures, as the deployment of the remaining S\$13.915 million could be a catalyst for share price movements.
BY ORDER OF THE BOARD
Madan Mohan
Company Secretary
3 June 2026
Disclaimer: This article is for informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research or consult a professional advisor before making investment decisions.
mDR Limited关于配股附认股权证发行所得款项使用情况的详细更新
主要亮点
- 净募集资金： 配股附认股权证发行后，扣除相关费用后，净募集资金为3,062.4万新元。
- 当前使用情况： 已拨付和使用1,670.9万新元于主要用途。
- 剩余余额： 仍有1,391.5万新元净募集资金可供未来使用。
- 按预期用途使用： 资金使用与招股说明书中披露的一致，体现了良好的治理和透明度。
- 持续披露： 公司将在剩余资金有重大使用时继续公告。
资金使用详情
mDR Limited（新加坡注册）公布了关于其配股附认股权证发行所得款项使用的最新进展。公司及其子公司共计净募集人民币3,062.4万新元（扣除约31万新元的相关费用及贷款结算后）。
使用明细
| 用途 | 已用金额（千新元） |
|---|---|
| 投资于上市证券 | 6,814 |
| 采购库存 | 7,978 |
| 支付供应商发票 | 1,917 |
| 已用合计 | 16,709 |
| 净募集资金余额 | 13,915 |
对股东的重要影响
- 资金用途与招股说明书中的规划完全一致，显示出公司治理规范，透明度高。
- 大额投资于上市证券（681.4万新元）和库存（797.8万新元），表明公司正积极推进战略布局，可能推动未来增长。
- 剩余1,391.5万新元为公司提供了灵活性，可用于未来扩张、营运资金或应对市场变化。
- 未来如有大额资金动用，公司将及时公告，这可能影响公司财务状况和股价。
潜在影响股价的信息
- 资金动用： 投资者应密切关注剩余1,391.5万新元未来的使用情况，重大投资或收购可能会影响股价。
- 按计划使用： 资金按计划使用有助于增强市场信心，或影响市场情绪。
结论
mDR Limited 负责任的披露和透明的资金分配体现了对股东利益的重视。投资者应关注后续公告，因剩余资金的重大动用可能成为推动股价变动的催化剂。
董事会命令
公司秘书：Madan Mohan
2026年6月3日
免责声明： 本文仅供参考，不构成投资建议或推荐。投资者应自行调查或咨询专业人士后再做投资决策。
